Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic.
Kamoun W, Swindell E, Pien C, Luus L, Cain J, Pham M, Kandela I, Huang ZR, Tipparaju SK, Koshkaryev A, Askoxylakis V, Kirpotin DB, Bloom T, Mino-Kenudson M, Marks JD, Zalutskaya A, Bshara W, Morrison C, Drummond DC.
Kamoun W, et al. Among authors: marks jd.
Pharmaceutics. 2020 Oct 20;12(10):996. doi: 10.3390/pharmaceutics12100996.
Pharmaceutics. 2020.
PMID: 33092175
Free PMC article.